Display Settings:

Format

Send to:

Choose Destination
    Mol Ther. 2011 Dec;19(12):2111-3. doi: 10.1038/mt.2011.254.

    Gene transfer using HACs: a key step closer to ex vivo gene therapy using autologous gene-corrected cells to treat muscular dystrophy.

    Source

    Unité de Recherche en Génétique Humaine, Centre de Recherche du CHUQ and Université Laval, Quebec, Canada. jacques-p.tremblay@crchul.ulaval.ca

    PMID:
    22134745
    [PubMed - indexed for MEDLINE]
    PMCID:
    PMC3242673
    [Available on 2012/12/1]

      Supplemental Content

      Icon for Nature Publishing Group

      Save items

      loading

      Recent activity

      Your browsing activity is empty.

      Activity recording is turned off.

      Turn recording back on

      See more...
      Write to the Help Desk